Real-world Treatment Patterns Among Patients with Generalized Myasthenia Gravis in the United States. (PubMed, Neurol Ther) - Oct 7, 2026 - "Conventional treatments were the predominant initial strategy for gMG, while immunoglobulin and advanced treatments became more common over successive treatment episodes. The high prevalence of MG-related clinical events within the first year post-gMG diagnosis, despite treatment with conventional therapies, suggests the need for more effective and earlier interventions."
HEOR • Journal • Real-world evidence • CNS Disorders • Immunology • Myasthenia Gravis
|
|
Anabelle Tardif-Samson; Antoine C El Khoury; Geoffroy Coteur; Kavita Gandhi; Kavita Grover; Martin Cloutier; Maryia Zhdanava; Porpong Boonmak; Yuxi Wang
|